Theyve transformed how we manage metabolic conditions, blood sugar, and weight
This timeline is notably slower than injectable tirzepatide, where most users notice significant appetite suppression within the first 1 to 2 weeks
Who Retatrutide Is For and Who Should Avoid It Retatrutide is currently studied in adults with obesity, adults with type 2 diabetes, and adults with weight-related conditions like knee osteoarthritis, sleep apnea, and metabolic dysfunction-associated steatotic liver disease (MASLD)
Call your doctor if: You experience rapid, unintentional weight loss or gain without a clear reason
Step 3: Prior Authorization and Delivery Should tirzepatide be prescribed, Klinic handles the prior authorization process with your insurer
Physiol ., 119 , 14191429